These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 35614875)

  • 1. Leicester Cough Questionnaire validation and clinically important thresholds for change in refractory or unexplained chronic cough.
    Nguyen AM; Schelfhout J; Muccino D; Bacci ED; La Rosa C; Vernon M; Birring SS
    Ther Adv Respir Dis; 2022; 16():17534666221099737. PubMed ID: 35614875
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Validation of a visual analog scale for assessing cough severity in patients with chronic cough.
    Martin Nguyen A; Bacci ED; Vernon M; Birring SS; Rosa C; Muccino D; Schelfhout J
    Ther Adv Respir Dis; 2021; 15():17534666211049743. PubMed ID: 34697975
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quantitative measurement properties and score interpretation of the Cough Severity Diary in patients with chronic cough.
    Martin Nguyen A; Bacci E; Dicpinigaitis P; Vernon M
    Ther Adv Respir Dis; 2020; 14():1753466620915155. PubMed ID: 32345170
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Content validity of the Leicester Cough Questionnaire in adults with refractory or unexplained chronic cough: a qualitative interview study.
    Martin Nguyen A; La Rosa C; Cornell AG; Sher MR; Bernstein JA; Birring SS; DeMuro Romano C; Mayorga M; Milien M; Ervin C
    Ther Adv Respir Dis; 2024; 18():17534666241274261. PubMed ID: 39235438
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Improvements in Objective and Subjective Measures of Chronic Cough with Gefapixant: A Pooled Phase 3 Efficacy Analysis of Predefined Subgroups.
    Smith JA; Birring SS; Dicpinigaitis PV; McGarvey LP; Morice AH; Pavord ID; Satia I; Green S; Iskold B; La Rosa C; Li Q; Martin Nguyen A; Schelfhout J; Muccino D
    Lung; 2022 Aug; 200(4):423-429. PubMed ID: 35895098
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Validity and reliability of the Swedish version of the Leicester Cough Questionnaire in unexplained chronic cough.
    Ternesten-Hasséus E; Johansson EL
    Respir Med; 2024 Apr; 224():107582. PubMed ID: 38428509
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical cough IV:what is the minimal important difference for the Leicester Cough Questionnaire?
    Raj AA; Pavord DI; Birring SS
    Handb Exp Pharmacol; 2009; (187):311-20. PubMed ID: 18825348
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development of an Italian version of the Leicester cough questionnaire and its relationship with other symptom-specific measures for patients with chronic cough.
    Sorano A; Fumagalli C; Cinelli E; Birring SS; Fontana GA; Lavorini F
    Respir Med; 2024 Jun; 227():107642. PubMed ID: 38670318
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of Patients With Refractory or Unexplained Chronic Cough Participating in a Phase 2 Clinical Trial of the P2X3-Receptor Antagonist Gefapixant.
    Morice AH; Birring SS; Smith JA; McGarvey LP; Schelfhout J; Martin Nguyen A; Xu ZJ; Wu WC; Muccino DR; Sher MR
    Lung; 2021 Apr; 199(2):121-129. PubMed ID: 33825965
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cough desensitization treatment for patients with refractory chronic cough: results of a second pilot randomized control trial.
    Slovarp LJ; Reynolds JE; Tolbert S; Campbell S; Welby S; Morkrid P
    BMC Pulm Med; 2023 Apr; 23(1):148. PubMed ID: 37118696
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Validity and reliability of the Thai version of the leicester cough questionnaire in chronic cough.
    Pornsuriyasak P; Kawamatawong T; Rattanasiri S; Tantrakul V; Pongmesa T; Birring SS; Thakkinstian A
    Asian Pac J Allergy Immunol; 2016 Sep; 34(3):212-216. PubMed ID: 27001649
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The validity and precision of the Leicester Cough Questionnaire in COPD patients with chronic cough.
    Berkhof FF; Boom LN; ten Hertog NE; Uil SM; Kerstjens HA; van den Berg JW
    Health Qual Life Outcomes; 2012 Jan; 10():4. PubMed ID: 22230731
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A phase 3, randomized, double-blind, clinical study to evaluate the long-term safety and efficacy of gefapixant in Japanese adult participants with refractory or unexplained chronic cough.
    Niimi A; Sagara H; Kikuchi M; Arano I; Sato A; Shirakawa M; La Rosa C; Muccino D
    Allergol Int; 2022 Oct; 71(4):498-504. PubMed ID: 35752582
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Validation of the Polish Version of the Chronic Cough Quality of Life Questionnaire (Leicester Cough Questionnaire).
    Dąbrowska M; Krakowiak K; Radlińska O; Rybka A; Grabczak EM; Maskey-Warzęchowska M; Korczyński P; Birring SS; Krenke R
    Adv Clin Exp Med; 2016; 25(4):649-53. PubMed ID: 27629838
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Validation of the French version of the Leicester Cough Questionnaire in chronic obstructive pulmonary disease.
    Reychler G; Schinckus M; Fremault A; Liistro G; Pieters T
    Chron Respir Dis; 2015 Nov; 12(4):313-9. PubMed ID: 26346891
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cross-cultural adaptation and validation of Leicester Cough Questionnaire in sarcoidosis: the persian version.
    Rahdar M; Kiani A; Noorali S; Bakhshandeh A; Hosseini-Baharanchi FS; Shafaghi S; Abedini A; Kharazmi AB
    Sarcoidosis Vasc Diffuse Lung Dis; 2024 Mar; 41(1):e2024006. PubMed ID: 38567558
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Normative Values for the Leicester Cough Questionnaire in Healthy Individuals.
    Reynolds JE; Jetté ME; Wright ML; Sundar KM; Gillespie AI; Slovarp LJ
    Ann Otol Rhinol Laryngol; 2023 Jun; 132(6):705-708. PubMed ID: 35833581
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Demographic, clinical, and patient-reported outcome data from 2 global, phase 3 trials of chronic cough.
    Dicpinigaitis PV; Birring SS; Blaiss M; McGarvey LP; Morice AH; Pavord ID; Satia I; Smith JA; La Rosa C; Li Q; Nguyen AM; Schelfhout J; Tzontcheva A; Muccino D
    Ann Allergy Asthma Immunol; 2023 Jan; 130(1):60-66. PubMed ID: 35569802
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development of a symptom specific health status measure for patients with chronic cough: Leicester Cough Questionnaire (LCQ).
    Birring SS; Prudon B; Carr AJ; Singh SJ; Morgan MD; Pavord ID
    Thorax; 2003 Apr; 58(4):339-43. PubMed ID: 12668799
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reliability and validity of Leicester Cough Questionnaire Korean version.
    Han JM; Jung IC; Kang W; Kim SS; Yeo Y; Park YC
    Chron Respir Dis; 2014 Aug; 11(3):147-152. PubMed ID: 24906688
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.